Advertisement
UK markets close in 6 hours 44 minutes
  • FTSE 100

    7,968.50
    +36.52 (+0.46%)
     
  • FTSE 250

    19,805.19
    -5.47 (-0.03%)
     
  • AIM

    741.35
    -0.76 (-0.10%)
     
  • GBP/EUR

    1.1681
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.2594
    -0.0044 (-0.35%)
     
  • Bitcoin GBP

    56,083.82
    +598.13 (+1.08%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CRUDE OIL

    81.69
    +0.34 (+0.42%)
     
  • GOLD FUTURES

    2,216.20
    +3.50 (+0.16%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,490.64
    +13.55 (+0.07%)
     
  • CAC 40

    8,243.07
    +38.26 (+0.47%)
     

2 Biotech Stocks Poised for Jaw-Dropping Growth

2 Biotech Stocks Poised for Jaw-Dropping Growth

Over the past 10 years, U.S. stocks have delivered outstanding returns for investors. The major stock indices such as the Dow Jones Industrial Average, the NASDAQ Composite, and the S&P 500 have all climbed by more than 200% during this boom period. For example, biotech innovators Axsome Therapeutics (NASDAQ: AXSM) and Moderna (NASDAQ: MRNA), along with electric-car giant Tesla (NASDAQ: TSLA), have all generated well over 1,000% returns on capital for investors in just the past three years.